To analyze associations among the serum endostatin level, renal function, and carotid atherosclerosis of healthy residents of Japan.
cellular matrix 6) , and a potent endogenous angiogenesis inhibitor in vivo and in vitro [7] [8] [9] . Collagen XVIII is a major component of the basal membranes, is highly expressed in kidney, and is found in the Bowman's capsule, as well as in the glomerular and tubular basal membranes 10, 11) . Cleavage of collagen XVIII during extracellular matrix (ECM) remodeling gives rise to the circulating endostatin level 12) . Over the past few years, several studies have reported an association
Introduction
Reduction in the glomerular filtration rate (GFR) is associated with an increased risk of cardiovascular disease [1] [2] [3] , end-stage renal disease, and all-cause mortality 4) . GFR is also used to diagnose, classify, and monitor chronic kidney disease (CKD) 5) . Endostatin is a cleavage of the C-terminal domain of collagen XVIII, a component of the extraCopyright©2018 Japan Atherosclerosis Society This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.
as weight [kg] divided by height [m] squared. Systolic and diastolic blood pressures (SBP and DBP) were measured on the right arm, in the sitting position, with an automated sphygmomanometer (HEM-780, Omron Healthcare, Kyoto, Japan) after a five-minute rest.
Each participant completed a self-administrated questionnaire to gather information about personal medical history, family medical history, use of drugs, smoking status (current or non-current), and alcohol consumption (habitual or non-habitual). The questionnaire was checked for unfilled or inconsistent answers, first by nurses and again by our staff physicians 22) .
Laboratory Measurements
As part of a free public physical examination, blood samples were collected after an 8-hour overnight fast to determine the serum levels of creatinine, hemoglobin A1c (HbA1c), low-density lipoprotein (LDL) cholesterol, and high sensitive C-reactive protein (hs-CRP) 22) . The serum level of high-density lipoprotein (HDL) cholesterol (Determiner L HDL-C and T, Kyowa Medex Co., Ltd, Tokyo, Japan), triglycerides (Determiner L TG II, Kyowa Medex Co., Ltd, Tokyo, Japan), and uric acid (L-Type UA F, Wako Pure Chemical Industries Co., Ltd, Osaka, Japan) were determined by automated, standardized enzymatic analysis. Aliquots of whole blood and fresh plasma and serum samples after separation were stored at 4 in refrigerated containers and sent to a commercial laboratory (SRL, Inc., Tokyo, Japan). The estimated GFR (eGFR) was calculated using the modification of diet in renal disease study equation modified for Japanese subjects: eGFR (mL/min/1.73m 2 ) 194 age 0.287 serum creatinine (mg/dL) 1.094 (if female 0.739) 25) . All remaining fasting serum samples were immediately frozen and stored at 80 until assayed. The serum endostatin level (range: 16-500 ng/mL) was measured from defrosted samples using a commercially available enzyme-linked immunosorbent assay kit (R&D Systems Inc., Minneapolis, USA). Assessment of reproducibility testing showed good results, the recovery rate for spiked samples was 91%-108%, and there was no influence of interfering substances at normal levels. The intra-and inter-assay coefficients of variation were 5.0% and 6.4%, respectively 22) .
Ultrasonographic Measurement
Carotid IMT was assessed by ultrasound 22) . Carotid artery lesions were measured using high-resolution B-mode ultrasonography with a 7.5 MHz linear array probe (UF-4300R®, Fukuda Denshi Co., Ltd, Tokyo, Japan) by the well-trained physicians of our department. Images were obtained 20 mm proximal to the origin of the carotid bulb at the far wall by between the circulating endostatin level and the renal function of CKD patients [13] [14] [15] [16] , the elderly population 12, 17, 18) , and diabetes patients 19) . Thus, it is well documented that serum endostatin is associated with renal function and can be a useful marker of CKD. However, the association between the serum endostatin level and the renal function of healthy individuals, including younger persons, is unclear.
Carotid intima-media thickness (IMT), a marker of subclinical atherosclerosis, is a predictor of the incidence of CKD 20, 21) . We previously showed a significant relation between serum endostatin and carotid atherosclerosis 22) . On the other hand, no studies have been done that have shown association of the serum endostatin level, CKD, and carotid IMT. This may be a basic information for using the serum endostatin level as a clinical marker. In this study, we did exploratory cross-sectional observational research about the impact of the serum endostatin level on the association between carotid atherosclerosis and the renal function in a healthy Japanese population.
Patients and Methods

Study Participants
This study is part of the Kyushu and Okinawa Population Study (KOPS) survey of vascular events associated with lifestyle-related diseases 23, 24) . For the present study, we used the same study population as in our previous KOPS report 22) . Study eligible participants were 1,057 residents who took part in free public physical examinations between 2010 and 2011. The following were excluded from analysis: 1) 28 because of insufficient data; 2) 44 who did not agree to undergo carotid ultrasonographic measurement; 3) 77 who had a history of cardiovascular disease, malignancy, or a chronic inflammatory disease (collagen disease, inflammatory bowel disease); 4) 260 receiving treatment for hypertension, diabetes, or dyslipidemia. After exclusions, the data of 648 subjects (200 men and 448 women) were available for analysis 22) . The age of the subjects ranged from 24 to 84 years (mean SD: 56.3 10.6 years). The study design was approved by the Kyushu University Hospital Ethics Committee (permission number: 590-00). Written informed consent was obtained from each participant prior to the examination. The study was conducted in accordance with the principles of the Helsinki Declaration of 1975, as revised in 2000.
Anthropometric Measurement and Questionnaire
Anthropometric measurements were performed with each participant wearing indoor clothing and without shoes. Body mass index (BMI) was calculated established relationship between carotid IMT and serum endostatin level; 3) an association between serum endostatin level and eGFR; and 4) after adjustment for serum endostatin, the association between carotid IMT and eGFR is no longer significant. The statistical analysis was performed using JMP Pro ver. 11 (SAS Institute Inc., Cary, NC, USA). A two-tailed P value 0.05 was considered statistically significant.
Results
Clinical Characteristics
The median endostatin level was 63.7 ng/mL (interquartile range: 49.7-93.2 ng/mL). The mean eGFR was 78.4 14.8 mL/min/1.73m 2 , and 54 participants (8.3%) had renal dysfunction (eGFR 60.0 mL/min/1.73m
2 ). Furthermore, the median endostatin level of subjects with (without) renal dysfunction was 101.8 (62.7) ng/mL [interquartile range: 70.3-127.9 (49.3-90.4) ng/mL]. The clinical characteristics of subjects with above (≥ 63.7 ng/mL) and below ( 63.7 ng/mL) median endostatin levels are presented in Table 1 . Subjects with above median endostatin had significantly lower eGFR (74.6 13.3 vs. 82.3 15.2 mL/min/1.73m 2 , P 0.001) and higher carotid IMT (0.71 0.14 vs. 0.65 0.09 mm, P 0.001) than those with below median endostatin. Age, sex, habitual drinking, SBP, DBP, HbA1c, LDL and HDL cholesterol level, and uric acid level were the IMT measurement software, Intimascope (Media Cross Co., Ltd, Tokyo, Japan) 26) . The mean value of the bilateral average mean-IMT level was used as the mean carotid IMT level.
Statistical Analysis
Data are presented as the means standard deviation (SD) or percentage. Because the distributions of the serum endostatin and hs-CRP levels were highly skewed 22) , they were log-transformed before the statistical analysis and expressed as the median (interquartile ranges). The univariate analysis for associations between eGFR and clinical variables was done using Pearson's correlation coefficient analysis (categorical variables were compared with the difference between groups). For comparisons of participants with an above/below median serum endostatin level, unpaired Student's t-test was used to compare mean values and the chi-square test was used to evaluate differences in prevalence rates. Multivariate linear regression was used to examine the association of eGFR and serum endostatin level after adjustment for the previously mentioned covariates. Mediation analysis was done using Baron and Kenny's regression approach 27) to investigate the mediating effect of serum endostatin level in the association between carotid IMT and eGFR. A stepwise approach was followed in which four conditions must be met: 1) an established association between the carotid IMT and eGFR; 2) an Data are presented as the mean standard deviation, median (interquartile ranges), or number of subjects (percent) for categorical variables. Overall P-values were calculated by unpaired t-test or chi-square test. HbA1c: hemoglobin A1c, LDL: low density lipoprotein, HDL: high density lipoprotein, hs-CRP: high sensitive C-reactive protein, IMT: intima-media thickness, eGFR: estimated glomerular filtration rate P 0.003), and log-transformed endostatin (r 0.36, P 0.001) to be significantly associated with eGFR ( Fig. 1) . In multiple linear regression, the log-transformed serum endostatin level was significantly correlated to eGFR ( Table 2) . Although carotid IMT and eGFR were related in univariate analysis, carotid IMT was not significantly associated with eGFR change after casting serum endostatin into a multiple linear regression. From this, the association between carotid IMT and eGFR may be mediated through serum endalso significantly different between the subjects with above and below median endostatin levels.
Association between eGFR, Endostatin, and Carotid IMT
Univariate analysis showed age (r 0.37, P 0.001), non current smoking (85. The direct mechanisms related to the elevation of serum endostatin level and renal dysfunction remain unclear. In this regard, we have previously shown that the serum endostatin level is independently associated with carotid IMT with vascular endothelial dysfunction and ECM remodeling 22) . Because atherosclerosis is a risk factor for the development of CKD, it is possible that the association between serum endostatin and renal function reflects the influence of an endostatin-producing increase derived from sclerotic blood vessels. On the other hand, it has been reported that circulating endostatin partly reflects renal ECM remodeling 12) . Elevation of the endostatin level may represent renal microvascular rarefaction and fibrosis in ECM remodeling in kidney 29) . We also referred to the possibility that an increase in the serum endostatin level is a useful marker for the early detection of kidney injury in our previous study of 161 residents with prediabetes 30) . The serum endostatin level may reflect not only a production increase derived from sclerotic blood vessels but also production derived from ischemia and fibrosis in kidney. Furthermore, it is necessary to consider the influence of renal clearance of circulating endostatin as well as the endostatin-producing increase. Urinary excretion was the major elimination route of endostatin in an animal experiment 31) . Elevation of serum endostatin level may be due to decreased renal clearance, similar to that of cystatin C. Both cystatin C and endostatin are of similar size and can pass through the glomerular barrier 12) . These findings suggest that serum endostatin strongly reflects ECM remodeling in blood vessels and the kidney, especially in healthy individuals or early renal injury patients and may better reflect decreased renal clearance in patients with severe renal dysfunction.
This study has some limitations. First, the crosssectional observational design makes it difficult to draw concrete inferences regarding causality between the serum endostatin level, carotid IMT, and eGFR. Second, we used the results of a single time measurement for our evaluation of serum endostatin. Third, the impact of age and sex on renal function might be stronger because eGFR was used to evaluate renal function. Finally, we did not evaluate urinary albumin. In spite of these limitations, this study is the first to show an association between the serum endostatin level, renal function, and subclinical atherosclerosis in a population of healthy residents of Japan. We believe that our findings will contribute the clarification of the usefulness of serum endostatin measurement in the management of CKD.
We found that the association between carotid IMT and eGFR is mediated by the serum endostatin ostatin level. To verify this, we did a Baron and Kenny analysis to determine if the requirements to demonstrate mediation were met 27) . eGFR (dependent variable) showed a positive association with carotid IMT (independent variable) [Model 1: beta 0.11, P 0.003]. The association between carotid IMT and logtransformed serum endostatin level (mediator) was significant [Model 2: beta 0.26, P 0.001]. Furthermore, there was a significant association between logtransformed serum endostatin level and eGFR [Model 3: beta 0.36, P 0.001]. After adjustment for logtransformed serum endostatin level, the association between carotid IMT and eGFR did not remain significant [Model 4: beta 0.02, P 0.568]. Additionally, the beta coefficient for eGFR in model 4 was lower than in model 1. Mediation analysis showed that the serum endostatin level could be considered as a (complete) mediator in the association between carotid IMT and eGFR.
Discussion
The main finding of the present study is that the association between carotid IMT and eGFR is mediated through the serum endostatin level of healthy individuals. Additionally, a high serum endostatin level was significantly associated with a decrease of eGFR in multiple linear regression adjusted for known covariates, including carotid IMT and traditional risk factors for atherosclerosis, such as blood pressure, blood glucose, and blood lipids, as reported in the data of a population-based study 28) . Recent observational studies have shown that the circulating endostatin level is associated with lower eGFR and higher albuminuria 12) , the severity of kidney dysfunction 13) , the CKD and CKD stage 14, 15) , and hypertensive target-organ damage including urinary albumin/creatinine ratio 17) and that it is a predictor of future mortality 18, 19) and cardiovascular events 16) . However, these studies were limited in CKD patients [13] [14] [15] [16] , an elderly population 12, 17, 18) , or diabetes patients 19) . In the present study, we extended the field to a healthy population that included younger persons who ranged from 24 to 84 years (mean SD: 56.3 10.6 years), which is epidemiologically and clinically important. Our findings suggest the possibility that serum endostatin would be a useful marker for the management of CKD, cardiovascular disease, and the mortality of healthy individuals, including younger persons. Although GFR has some problems as a surrogate marker of CKD, it is generally used to diagnose, classify, and monitor CKD 5) and is considered to be an independent risk factor of cardiovascular disease [1] [2] [3] , end-stage renal disease, and all-cause mortality 4) . GFR level of healthy Japanese residents. Future, longitudinal studies will be necessary to assess the clinical usefulness of the circulating endostatin level as an indicator of future CKD, especially for healthy individuals or those with early renal impairment. 
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